Key Takeaways
- NuScale stands as the sole American nuclear firm with NRC approval for its SMR technology, providing a significant regulatory advantage.
- First-quarter 2026 revenue totaled a mere $565,000 — a staggering 95.8% decline from the prior year — falling far short of the $7 million analyst forecast.
- Shares currently hover between $12 and $13, representing a devastating 65% drop from 12 months ago, while the 52-week peak reached $57.42.
- Company insiders conducted substantial selling, notably Director Corp Fluor who dumped 13.5 million shares in April for approximately $159 million.
- Analyst community maintains a “Hold” consensus with a mean price objective of $15.92, even as institutional stakeholders control 78.37% of shares.
NuScale Power (SMR) currently changes hands below the $13 mark, positioned approximately 65% beneath its valuation from twelve months prior. This substantial disconnect between market price and theoretical value has captured investor interest — though the underlying financial data presents a complex picture.
NuScale Power Corporation, SMR
Shares commenced Thursday’s session at $12.05, operating within a 52-week bandwidth spanning $8.85 to $57.42. The company commands a market capitalization hovering around $4.4 to $4.5 billion — a substantial valuation for an enterprise generating merely $565,000 in quarterly revenue.
The first-quarter performance wasn’t simply underwhelming — it dramatically undershot the $7 million analyst projection by an enormous margin. Revenue contracted 95.8% compared to the same period last year, while the company recorded a $57 million operating deficit for the quarter.
NuScale disclosed Q1 earnings per share of -$0.14, falling short of the -$0.11 consensus forecast. Wall Street projects full-year EPS at -$0.79.
Why NuScale Could Succeed
The optimistic investment thesis centers on regulatory positioning. NuScale maintains exclusive status as the only nuclear reactor company in America possessing NRC certification for its small modular reactor (SMR) technology. Competitors such as Oklo and Nano Nuclear Energy lack this critical approval and may require years to obtain similar authorization.
NuScale currently advances two operational initiatives. The company collaborates with a Romanian utility partner to construct a 462-megawatt electric facility at a decommissioned coal location. Domestically, through its ENTRA1 partnership, it pursues 6 gigawatts of SMR deployment for the Tennessee Valley Authority.
Both ventures are scheduled for completion no earlier than 2030. Consequently, NuScale operates essentially as a pre-revenue enterprise carrying a multi-billion dollar market capitalization.
The firm does maintain substantial financial reserves — approximately $1 billion in total liquidity, encompassing $341 million in cash and cash equivalents. While this provides operational runway, it doesn’t produce immediate shareholder returns.
Insider Selling Pressure vs. Institutional Support
Recent insider transactions warrant careful examination. During the previous 90-day period, company insiders divested over 40 million shares valued at nearly $475 million. The most significant transaction involved Director Corp Fluor, which liquidated 13.5 million shares throughout April at a mean price of $11.81, generating proceeds exceeding $159 million.
Company insiders currently maintain ownership of merely 1.28% of outstanding shares.
Conversely, institutional investors retain control of 78.37% of the stock. Seven Grand Managers LLC established a fresh position valued at $1.77 million during Q4. Multiple additional funds — including MAI Capital Management and Harbour Investments — expanded their existing stakes.
Wall Street sentiment remains divided. B. Riley reduced its price objective from $24 to $19 while maintaining a “Buy” recommendation. HSBC initiated coverage with a “Hold” rating and $13 target. Royal Bank of Canada lowered its target from $21 to $14. TD Cowen downgraded the stock from “Buy” to “Hold” this past February.
The aggregate view among 17 covering analysts stands at “Hold,” featuring an average price target of $15.92 — representing roughly 25% upside from current trading levels.
NuScale’s 50-day simple moving average registers at $11.41 while its 200-day moving average sits at $15.38, with shares presently trading in the zone between these technical benchmarks.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
